JP2002539204A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002539204A5 JP2002539204A5 JP2000605578A JP2000605578A JP2002539204A5 JP 2002539204 A5 JP2002539204 A5 JP 2002539204A5 JP 2000605578 A JP2000605578 A JP 2000605578A JP 2000605578 A JP2000605578 A JP 2000605578A JP 2002539204 A5 JP2002539204 A5 JP 2002539204A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- composition according
- compound according
- nhco
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 14
- 239000000203 mixture Substances 0.000 description 11
- 125000002252 acyl group Chemical group 0.000 description 5
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000002202 Polyethylene glycol Chemical group 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229920001223 polyethylene glycol Chemical group 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 108090000765 processed proteins & peptides Chemical group 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- -1 methoxy, hydroxy Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001542 oligosaccharide Chemical group 0.000 description 1
- 150000002482 oligosaccharides Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001308 poly(aminoacid) Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU9139 | 1999-03-12 | ||
| AUPP9139A AUPP913999A0 (en) | 1999-03-12 | 1999-03-12 | Novel chemical compounds and their use |
| AUPP9139 | 1999-03-12 | ||
| PCT/AU2000/000165 WO2000055149A1 (en) | 1999-03-12 | 2000-03-09 | Dimeric compounds and as inhibitors of neuraminidase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002539204A JP2002539204A (ja) | 2002-11-19 |
| JP2002539204A5 true JP2002539204A5 (enExample) | 2007-04-19 |
| JP5160000B2 JP5160000B2 (ja) | 2013-03-13 |
Family
ID=3813338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000605578A Expired - Fee Related JP5160000B2 (ja) | 1999-03-12 | 2000-03-09 | 二量体化合物およびニューラミニダーゼ阻害剤として |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6548476B1 (enExample) |
| EP (1) | EP1165541B1 (enExample) |
| JP (1) | JP5160000B2 (enExample) |
| KR (1) | KR100805906B1 (enExample) |
| CN (1) | CN1343205A (enExample) |
| AP (1) | AP2001002277A0 (enExample) |
| AT (1) | ATE295361T1 (enExample) |
| AU (2) | AUPP913999A0 (enExample) |
| BR (1) | BR0008939A (enExample) |
| CA (1) | CA2367755C (enExample) |
| CZ (1) | CZ20013274A3 (enExample) |
| DE (1) | DE60020100T2 (enExample) |
| EA (1) | EA200100968A1 (enExample) |
| ES (1) | ES2241581T3 (enExample) |
| HK (1) | HK1041693B (enExample) |
| HU (1) | HUP0200190A3 (enExample) |
| ID (1) | ID29868A (enExample) |
| IL (1) | IL145346A (enExample) |
| MX (1) | MXPA01009203A (enExample) |
| NO (1) | NO327812B1 (enExample) |
| NZ (1) | NZ514041A (enExample) |
| PL (1) | PL350228A1 (enExample) |
| TR (1) | TR200102794T2 (enExample) |
| TW (1) | TWI268279B (enExample) |
| WO (1) | WO2000055149A1 (enExample) |
| ZA (1) | ZA200107450B (enExample) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000068986A (ko) * | 1996-11-14 | 2000-11-25 | 리차드웨드레이 | 신규 용도 화합물 및 그 제조방법 |
| DE19930177B4 (de) | 1999-06-30 | 2007-02-08 | Nikolai Vladimirovich Bovin | Intermolekular assoziierende Verbindungen und deren Verwendung |
| AUPQ288499A0 (en) | 1999-09-16 | 1999-10-07 | Biota Scientific Management Pty Ltd | Antiviral agents |
| AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879701A0 (en) | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| CA2462337C (en) * | 2001-11-09 | 2011-09-27 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| AUPR879401A0 (en) | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879501A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AU2002336823B2 (en) * | 2001-11-09 | 2008-03-20 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| AUPR879601A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AU2002340635B2 (en) * | 2001-11-09 | 2008-03-13 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| AU2002340632B2 (en) * | 2001-11-09 | 2008-03-20 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| BR122012021252B8 (pt) | 2002-09-06 | 2021-05-25 | Cerulean Pharma Inc | polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência |
| US7144450B2 (en) * | 2004-12-04 | 2006-12-05 | Xerox Corporation | Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7317122B2 (en) | 2004-12-04 | 2008-01-08 | Xerox Corporation | Curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7314949B2 (en) | 2004-12-04 | 2008-01-01 | Xerox Corporation | Trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7220300B2 (en) | 2004-12-04 | 2007-05-22 | Xerox Corporation | Phase change inks containing bis(urea-urethane) compounds |
| US7576235B2 (en) | 2004-12-04 | 2009-08-18 | Xerox Corporation | Processes for preparing bis(urea-urethane) compounds |
| US7153349B2 (en) | 2004-12-04 | 2006-12-26 | Xerox Corporation | Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7560587B2 (en) | 2004-12-04 | 2009-07-14 | Xerox Corporation | Bis[urea-urethane] compounds |
| CA2675934C (en) * | 2007-01-23 | 2015-09-15 | Therapicon Srl | Antiviral compounds |
| JP2010516625A (ja) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス， インコーポレイテッド | 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート |
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| EP2173759A4 (en) | 2007-07-03 | 2014-01-29 | Childrens Hosp & Res Ct Oak | OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE |
| EP2173166A4 (en) * | 2007-07-03 | 2010-08-11 | Childrens Hosp & Res Ct Oak | POLYSIALIC ACID DE-N-ACETYLASE HEMMER AND METHOD OF USE THEREOF |
| EP2183261A4 (en) | 2007-07-03 | 2010-09-15 | Childrens Hosp & Res Ct Oak | POLYSIALYLIC ACID DERIVATIVES, MANUFACTURING METHODS AND APPLICATIONS FOR INCREASING THE PRODUCTION AND TARGETING OF CANCER ANIMALS |
| EP2318832B1 (en) | 2008-07-15 | 2013-10-09 | Academia Sinica | Glycan arrays on ptfe-like aluminum coated glass slides and related methods |
| CA2774015A1 (en) * | 2009-09-15 | 2011-03-24 | Cerulean Pharma Inc. | A cdp-camptothecin conjugate, particle or composition and uses thereof |
| NL2005389A (en) | 2009-10-21 | 2011-04-26 | Asml Netherlands Bv | Lithographic apparatus, device manufacturing method, and method of applying a pattern to a substrate. |
| IT1396620B1 (it) * | 2009-11-25 | 2012-12-14 | Therapicon Srl | Analoghi chimerici |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| US20130225523A1 (en) * | 2010-08-24 | 2013-08-29 | Imperial Innovations Limited | Glycodendrimers of polypropyletherimine |
| CN104080450A (zh) * | 2012-01-05 | 2014-10-01 | 阿拉维制药公司 | 扎那米韦生物利用度增强的制剂 |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| EP2885311B1 (en) | 2012-08-18 | 2020-01-01 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
| US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
| WO2015035337A1 (en) | 2013-09-06 | 2015-03-12 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US9982041B2 (en) | 2014-01-16 | 2018-05-29 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| EP3129767B1 (en) | 2014-03-27 | 2021-09-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| AU2015267051B2 (en) | 2014-05-27 | 2022-03-17 | Academia Sinica | Fucosidase from bacteroides and methods using the same |
| CN106573971A (zh) | 2014-05-27 | 2017-04-19 | 中央研究院 | 抗cd20醣抗体及其用途 |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| CA2950440A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| CN106714829A (zh) | 2014-05-28 | 2017-05-24 | 中央研究院 | 抗TNF‑α醣抗体及其用途 |
| US9879042B2 (en) | 2014-09-08 | 2018-01-30 | Academia Sinica | Human iNKT cell activation using glycolipids |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| AU2015378564A1 (en) | 2015-01-24 | 2017-07-13 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| EA033921B9 (ru) * | 2015-11-20 | 2020-01-22 | Острэлиан Байомедикал Ко. Пти Лтд | Производные сиаловой кислоты и их применение в лечении инфекций, вызываемых вирусом гриппа |
| RU2612221C1 (ru) * | 2015-12-16 | 2017-03-03 | Общество с ограниченной ответственностью "Синтавр" | Блокаторы вируса гриппа |
| KR20180114210A (ko) | 2016-03-08 | 2018-10-17 | 아카데미아 시니카 | N-글리칸의 모듈 합성 방법 및 그의 어레이 |
| US10538592B2 (en) | 2016-08-22 | 2020-01-21 | Cho Pharma, Inc. | Antibodies, binding fragments, and methods of use |
| CN108003065B (zh) * | 2016-10-27 | 2021-01-08 | 中国石油化工股份有限公司 | 一种具有增稠作用的化合物和润滑脂以及它们的制备方法 |
| WO2018199798A1 (ru) * | 2017-04-28 | 2018-11-01 | Общество с ограниченной ответственностью "Синтавр" | Пептидные производные противовирусного препарата занамивира |
| US11773129B2 (en) * | 2017-05-25 | 2023-10-03 | The Governors Of The University Of Alberta | Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase |
| CN111698999A (zh) * | 2017-12-06 | 2020-09-22 | 阿道恰公司 | 包含至少一种pi在5.8与8.5之间的基础胰岛素和带有羧酸根电荷及疏水基的共聚氨基酸的ph为7的可注射溶液 |
| BR112021004266A2 (pt) * | 2018-09-06 | 2021-08-03 | Cidara Therapeutics, Inc. | conjugados, população de conjugados, composição farmacêutica e métodos para o tratamento de um sujeito com uma infecção viral e para o tratamento profilático |
| KR20250107952A (ko) * | 2018-10-05 | 2025-07-14 | 에모리 유니버시티 | 단량체 및 다량체 항-hbv 제제 |
| TWI861205B (zh) | 2019-09-06 | 2024-11-11 | 美商席達拉醫療有限公司 | 用於治療病毒感染之組合物及方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0489162A4 (en) * | 1990-02-27 | 1993-09-29 | Drug Delivery System Institute, Ltd. | Derivative of glycolipid containing sialic acid |
| CA2106301C (en) * | 1991-03-18 | 1999-04-06 | Chi-Huey Wong | Oligosaccharide enzyme substrates and inhibitors: method and compositions |
| EP0638085A1 (en) * | 1992-02-19 | 1995-02-15 | The Biomembrane Institute | Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| JPH0638784A (ja) * | 1992-03-30 | 1994-02-15 | Meiji Milk Prod Co Ltd | シアル酸を構成要素とする糖鎖の製造方法 |
| ZA937034B (en) * | 1992-09-24 | 1995-06-23 | Brigham & Womens Hospital | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines |
| US5658880A (en) * | 1993-06-16 | 1997-08-19 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
| US5837689A (en) * | 1993-06-16 | 1998-11-17 | Glycomed Incorporated | Sialyl lewis-x mimetics containing naphthyl backbones |
| KR100447096B1 (ko) * | 1995-02-27 | 2005-10-11 | 갈리드사이언스인코오퍼레이티드 | 바이러스성또는세균성뉴라미니다제의신규한선택적저해제 |
| US5780606A (en) * | 1995-06-07 | 1998-07-14 | Connaught Laboratories Limited | Neisseria meningitidis capsular polysaccharide conjugates |
| IL125662A0 (en) | 1996-03-01 | 1999-04-11 | Biota Scient Management | Method of detecting influenza virus and compounds for use therein |
| US5891862A (en) * | 1996-03-15 | 1999-04-06 | Geltex Pharmaceuticals, Inc. | Polyvalent polymers for the treatment of rotavirus infection |
| AUPO104396A0 (en) | 1996-07-17 | 1996-08-08 | Biomolecular Research Institute Limited | Antiviral linear polymers |
| EP0926154B1 (en) * | 1996-07-23 | 2010-01-27 | Seikagaku Corporation | Novel lactosamine oligosaccharides and process for the preparation thereof |
| KR20000068986A (ko) | 1996-11-14 | 2000-11-25 | 리차드웨드레이 | 신규 용도 화합물 및 그 제조방법 |
| JPH10182686A (ja) * | 1996-12-26 | 1998-07-07 | Ngk Insulators Ltd | ガングリオシドＧＱ１ｂ類縁物質 |
| US6267242B1 (en) | 1997-04-17 | 2001-07-31 | Johnson & Johnson Medical Kabushiki Kaisha | Chemical indicator sheets and packaging bags for sterilization made with the use of the same |
| EP1085846A2 (en) | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
-
1999
- 1999-03-12 AU AUPP9139A patent/AUPP913999A0/en not_active Abandoned
-
2000
- 2000-03-09 BR BR0008939-7A patent/BR0008939A/pt not_active IP Right Cessation
- 2000-03-09 MX MXPA01009203A patent/MXPA01009203A/es active IP Right Grant
- 2000-03-09 TR TR2001/02794T patent/TR200102794T2/xx unknown
- 2000-03-09 KR KR1020017011546A patent/KR100805906B1/ko not_active Expired - Fee Related
- 2000-03-09 PL PL00350228A patent/PL350228A1/xx unknown
- 2000-03-09 EP EP00907354A patent/EP1165541B1/en not_active Expired - Lifetime
- 2000-03-09 CN CN00804901A patent/CN1343205A/zh active Pending
- 2000-03-09 ID IDW00200101979A patent/ID29868A/id unknown
- 2000-03-09 AP APAP/P/2001/002277A patent/AP2001002277A0/en unknown
- 2000-03-09 ES ES00907354T patent/ES2241581T3/es not_active Expired - Lifetime
- 2000-03-09 AU AU28966/00A patent/AU774222B2/en not_active Ceased
- 2000-03-09 AT AT00907354T patent/ATE295361T1/de not_active IP Right Cessation
- 2000-03-09 HK HK02103316.9A patent/HK1041693B/en not_active IP Right Cessation
- 2000-03-09 CA CA002367755A patent/CA2367755C/en not_active Expired - Fee Related
- 2000-03-09 NZ NZ514041A patent/NZ514041A/xx not_active Application Discontinuation
- 2000-03-09 HU HU0200190A patent/HUP0200190A3/hu unknown
- 2000-03-09 CZ CZ20013274A patent/CZ20013274A3/cs unknown
- 2000-03-09 DE DE60020100T patent/DE60020100T2/de not_active Expired - Lifetime
- 2000-03-09 IL IL14534600A patent/IL145346A/xx not_active IP Right Cessation
- 2000-03-09 WO PCT/AU2000/000165 patent/WO2000055149A1/en not_active Ceased
- 2000-03-09 EA EA200100968A patent/EA200100968A1/ru unknown
- 2000-03-09 JP JP2000605578A patent/JP5160000B2/ja not_active Expired - Fee Related
- 2000-09-08 TW TW089118492A patent/TWI268279B/zh not_active IP Right Cessation
- 2000-09-08 US US09/658,445 patent/US6548476B1/en not_active Expired - Lifetime
-
2001
- 2001-09-10 ZA ZA200107450A patent/ZA200107450B/xx unknown
- 2001-09-11 NO NO20014409A patent/NO327812B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002539204A5 (enExample) | ||
| JP5160000B2 (ja) | 二量体化合物およびニューラミニダーゼ阻害剤として | |
| JP2004507564A5 (enExample) | ||
| JP2008531704A5 (enExample) | ||
| JP2004504406A5 (enExample) | ||
| JP2006527185A5 (enExample) | ||
| US6740635B2 (en) | Antiviral linear polymers | |
| RU2003127395A (ru) | Содержащие пэг конъюгаты hgf-nk4 | |
| JP5465182B2 (ja) | ポリアルキレンイミンを含むウイルス感染症治療薬 | |
| CN102775458A (zh) | β-D-(2’R)-2’-脱氧—2’-氟-2’-C-甲基胞苷衍生物的制备及用途 | |
| KR890006228A (ko) | 항종양제로서 폴리아민 유도체 | |
| CA2463835A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| US20230263900A1 (en) | Dendrimer-drug conjugate | |
| CA2462337A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| JP2006515629A (ja) | 吸収促進剤 | |
| US20100267616A1 (en) | Acute respiratory syndromes | |
| JP2025505673A (ja) | Ｃｏｖｉｄ感染症を処置するための方法および組成物 | |
| JP2007537280A (ja) | 免疫調節性化合物を用いる呼吸器のウイルス感染の治療又は予防 | |
| JP2006524704A (ja) | アルファチモシンペプチドによる呼吸器ウイルス感染の治療または予防 | |
| JP2011016804A5 (enExample) | ||
| CA2462345A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| JPWO2004083186A1 (ja) | ウイルス性肝炎治療剤及び制癌剤 | |
| CA2463865A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| Asmar et al. | Antiviral therapy: Respiratory infections, chornic hepatitis |